Terrance Coyne's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 22,487 Class A Ordinary Shares done at an average price of $46.7 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 46.67 per share. | 02 Mar 2026 | 22,487 | 109,177 | - | 46.7 | 1,049,507 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 02 Mar 2026 | 10,429 | 98,748 | - | 47.0 | 490,314 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 46.67 per share. | 02 Mar 2026 | 1,292 | 46,344 | - | 46.7 | 60,304 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 02 Mar 2026 | 583 | 45,761 | - | 47.0 | 27,409 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 23 Feb 2026 | 32,916 | 131,664 | - | 45.3 | 1,491,638 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 23 Feb 2026 | 1,875 | 47,636 | - | 45.3 | 84,968 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 26,626 | 49,511 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 42.84 per share. | 02 Feb 2026 | 108,759 | 183,656 | - | 42.8 | 4,659,584 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 42.08 per share. | 02 Feb 2026 | 102,581 | 292,415 | - | 42.1 | 4,317,009 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 02 Feb 2026 | 19,076 | 164,580 | - | 43.3 | 825,853 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 42.84 per share. | 02 Feb 2026 | 6,195 | 23,972 | - | 42.8 | 265,413 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 42.08 per share. | 02 Feb 2026 | 5,843 | 30,167 | - | 42.1 | 245,896 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 02 Feb 2026 | 1,087 | 22,885 | - | 43.3 | 47,059 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.35 per share. | 20 Jan 2026 | 65,832 | 394,996 | - | 39.3 | 2,590,384 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.35 per share. | 20 Jan 2026 | 3,750 | 36,010 | - | 39.3 | 147,557 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.42 per share. | 02 Jan 2026 | 65,832 | 460,828 | - | 38.4 | 2,528,982 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.42 per share. | 02 Jan 2026 | 3,750 | 39,760 | - | 38.4 | 144,059 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.36 per share. | 15 Dec 2025 | 65,832 | 526,660 | - | 38.4 | 2,525,322 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.36 per share. | 15 Dec 2025 | 3,750 | 43,510 | - | 38.4 | 143,850 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.87 per share. | 01 Dec 2025 | 65,832 | 592,492 | - | 39.9 | 2,624,459 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.87 per share. | 01 Dec 2025 | 3,750 | 47,260 | - | 39.9 | 149,498 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.67 per share. | 24 Nov 2025 | 55,146 | 669,010 | - | 38.7 | 2,132,292 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 37.96 per share. | 24 Nov 2025 | 10,686 | 658,324 | - | 38.0 | 405,645 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 38.67 per share. | 24 Nov 2025 | 3,126 | 51,634 | - | 38.7 | 120,882 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 37.96 per share. | 24 Nov 2025 | 624 | 51,010 | - | 38.0 | 23,687 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.30 per share. | 17 Nov 2025 | 65,844 | 724,156 | - | 39.3 | 2,587,939 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.30 per share. | 17 Nov 2025 | 3,750 | 54,760 | - | 39.3 | 147,390 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2025 | 6,168 | 58,510 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 3,696 | 52,342 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2025 | 1,000 | 43,350 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 1,807,277 | 1,807,277 | - | - | Class E Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 48,646 | 48,646 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 2,000 | 44,350 | - | - | ICAI Interests | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2023 | 1,650 | 46,350 | - | - | ICAI Interests | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 12 Jul 2023 | 37,500 | 865,000 | - | 30.9 | 1,159,958 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 31.07 per share. | 12 Jul 2023 | 37,500 | 902,500 | - | 31.1 | 1,165,256 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.47 per share. | 08 Nov 2022 | 24,500 | 940,000 | - | 43.5 | 1,065,013 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.06 per share. | 02 Nov 2022 | 5,500 | 964,500 | - | 43.1 | 236,846 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 43.19 per share. | 01 Aug 2022 | 30,000 | 970,000 | - | 43.2 | 1,295,727 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | 07 May 2021 | 1,000,000 | 1,000,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | 07 May 2021 | 100,000 | 22,945 | - | - | LP interests in RPI US Partners 2019, LP |